CLINICAL-FEATURE IN PATIENTS WITH HOMOZYGOUS AND HETEROZYGOUS FACTOR-V LEIDEN MUTATION (APC-RESISTANCE) AND A HISTORY OF VENOUS THROMBOEMBOLISM

被引：0
|
作者：
RINTELEN, C
BAYSTON, TA
IRELAND, H
LANE, DA
MANNHALTER, C
PABINGER, I
机构：
[1] UNIV HOSP VIENNA,CLIN INST LAB MED,VIENNA,AUSTRIA
[2] CHARING CROSS & WESTMINSTER MED SCH,DEPT HAEMATOL,LONDON,ENGLAND
[3] UNIV HOSP VIENNA,MED CLIN I,DEPT HAEMATOL & BLOOD COAGULANT,VIENNA,AUSTRIA
来源：
THROMBOSIS AND HAEMOSTASIS | 1995年 / 73卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1124 / 1124
页数：1
相关论文
共 50 条
  • [1] FACTOR-V MISSENSE MUTATION AND APC-RESISTANCE IN PATIENTS WITH VENOUS THROMBOEMBOLISM
    MA, DDF
    WILLIAMS, BG
    ABOUD, MR
    ISBISTER, JP
    BLOOD, 1994, 84 (10) : A84 - A84
  • [2] Patients with persistent APC-resistance without factor V Leiden mutation
    Schwarz, T
    Siegert, G
    Mikulin, U
    Gehrisch, S
    Runge, E
    Berg, LP
    Koch, R
    Schellong, SM
    VASA-JOURNAL OF VASCULAR DISEASES, 2001, 30 (01): : 24 - 27
  • [3] Is recurrent venous thromboembolism more frequent in homozygous patients for the factor V Leiden mutation than in heterozygous patients?
    Aillaud, MF
    Morange, P
    Juhan, I
    Bauters, A
    Trillot, N
    Jude, B
    Biron-Andréani, C
    Daures, JP
    Schved, JF
    Pernod, G
    Polack, B
    Borg, JY
    Saladin-Théron, C
    LeCam-Duchez, V
    Bridey, F
    De Prost, D
    Denninger, MH
    Truchaud, F
    Trossaërt, M
    Boinot, C
    Dutrillaux, F
    Vollot, F
    Lorenzini, JL
    Delahousse, B
    Fimbel, B
    Gruel, Y
    Houbouyan, L
    Vergnes, C
    Freyburger, G
    Lequerrec, A
    Favier, R
    BLOOD COAGULATION & FIBRINOLYSIS, 2003, 14 (06) : 523 - 529
  • [4] FACTOR-V (FV) LEIDEN MUTATION (APC-RESISTANCE) INCREASES THE RISK FOR VENOUS THROMBOEMBOLISM IN PATIENTS WITH A GENE DEFECT OF THE PROTEIN-C (PC) OR PROTEIN-S (PS) GENE
    PABINGER, I
    MUSTAFA, S
    RINTELEN, C
    KYRLE, PA
    LECHNER, K
    MANNHALTER, C
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1361 - 1361
  • [5] Prevalence of APC-resistance/factor V Leiden in venous or arterial thrombosis in Spain
    Gómez-Rioja, R
    Lopez-Pastor, A
    Cuesta, MV
    García-Muñoz, MS
    Fernández-Chacón, JL
    Fernández-Pavón, A
    THROMBOSIS AND HAEMOSTASIS, 1999, : 771 - 772
  • [6] Evaluation of recurrent venous thromboembolism in patients with Factor V Leiden mutation in heterozygous form
    Sveinsdotti, Signy V.
    Saemundsson, Ymir
    Isma, Nazim
    Gottsater, Anders
    Svensson, Peter J.
    THROMBOSIS RESEARCH, 2012, 130 (03) : 467 - 471
  • [7] APC RESISTANCE DUE TO FACTOR-V MISSENCE MUTATION IN PEDIATRIC-PATIENTS WITH THROMBOEMBOLISM
    CAPRINO, D
    ACQUILA, M
    ODINO, S
    FRANCHINI, E
    MORI, PG
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1371 - 1371
  • [8] FACTOR-V LEIDEN MUTATION AND VENOUS THROMBOSIS
    DAVIES, KA
    IRELAND, H
    ATHANASSIOU, P
    LOIZOU, S
    LANE, D
    WALPORT, MJ
    LANCET, 1995, 345 (8942): : 132 - 133
  • [9] FACTOR-V LEIDEN MUTATION AND VENOUS THROMBOSIS
    OZSOYLU, S
    LANCET, 1995, 345 (8942): : 133 - 133
  • [10] EVALUATION OF APC RESISTANCE IN THE PLASMA OF PATIENTS WITH Q506 MUTATION OF FACTOR-V (FACTOR-V LEIDEN) AND TREATED BY ORAL ANTICOAGULANTS
    CADROY, Y
    SIE, P
    ALHENCGELAS, M
    AIACH, M
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (04) : 734 - 735
12345